Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroprotection in acute ischemic stroke.

Jacques De Keyser1, Maarten Uyttenboogaart, Marcus W Koch

  • 1Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands. j.h.a.de.keyser@neuro.azg.nl

Acta Neurologica Belgica
|November 1, 2005
PubMed
Summary

Immediate neuroprotection for acute ischemic stroke is crucial, focusing on rapid vessel recanalization and preventing secondary brain damage. While neuroprotective drugs have faced challenges, ongoing research in stroke care shows promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In-Stent Stenosis or Occlusion After Carotid Artery Stenting in Patients Treated With Anticoagulants vs Antiplatelet Therapy.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026
Same author

Noninvasive neurophysiological diagnostics of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a scoping review.

Acta neurochirurgica·2026
Same author

Endovascular treatment in patients with renal dysfunction: results of the MR CLEAN Registry.

European stroke journal·2026
Same author

Cost-Effectiveness of Thrombectomy With or Without Alteplase in Large Vessel Occlusion Stroke: A Meta-Analysis Considering Time-to-Treatment.

Neurology·2026
Same author

Asymptomatic Carotid Stenosis and Cognition: A Contemporary Narrative Review of Cerebral Perfusion and Cerebrovascular Reserve.

Annals of vascular surgery·2026
Same author

Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry·2026

Area of Science:

  • Neurology
  • Emergency Medicine
  • Critical Care

Background:

  • Acute ischemic stroke requires immediate neuroprotection starting at the scene and continuing in the ambulance.
  • Key elements include managing airway, breathing, circulation, temperature, and blood glucose.
  • Preventing secondary brain damage from factors like hypoxemia and hypotension is vital.

Purpose of the Study:

  • To outline essential neuroprotective strategies for acute ischemic stroke patients.
  • To review the effectiveness of current treatments like thrombolysis and discuss the challenges in neuroprotective drug development.
  • To highlight the importance of stroke unit care and monitoring.

Main Methods:

  • Review of meta-analysis data on thrombolysis time windows.

Related Experiment Videos

  • Discussion of critical care parameters for neuroprotection (oxygenation, blood pressure, temperature, glucose).
  • Analysis of factors contributing to the failure of neuroprotective drugs in clinical trials.

    • Main Results:

    • Systemic thrombolysis is effective within 4.5 hours, with time windows extending to 6 hours for intravascular thrombolysis.
    • Intensive control of physiological parameters significantly aids in preventing secondary brain damage.
    • Despite disappointing clinical trial results for neuroprotective drugs, lessons learned may improve future research.

    Conclusions:

    • Early and continuous neuroprotection, including rapid reperfusion and meticulous secondary brain damage prevention, is paramount in acute ischemic stroke.
    • While neuroprotective agents have not yet succeeded in clinical trials, research is ongoing, with mild induced hypothermia being investigated.
    • Optimizing stroke care pathways and refining clinical trial designs are essential for advancing neuroprotection strategies.